Linear Capital Is Hiring Overseas Interns
We focus on early-stage ventures powered by breakthrough technology, striving to be the investors who most deeply understand tech — while also being lovable geeks with serious business and strategic chops.
线性资本
@linearcapital
专注前沿科技早期投资
484 articles
Articles
Linear Capital will host an exchange event in Munich this April with the University of Chinese Academy of Sciences (UCAS) and the China University of Science and Technology (USTC) Munich Alumni Associations, with a focus on frontier technologies.
Last spring, Linear Capital visited top European universities, toured three major robotics labs, and other important innovation platforms. We not only experienced firsthand the research and frontier technologies of countries like the UK, France, and Germany, but also had extensive exchanges and preliminary discussions with local student organizations and entrepreneurs. In 2024, we will deepen our engagement with European university organizations, alumni associations, and entrepreneurship clubs through richer formats and more exchanges. **In mid-April, the Linear Capital investment team**
Spring Tide Surges — Setting Sail at the Right Moment: DBS Group × Linear Capital New Year Closed-Door Exchange Successfully Held
In early March, Linear Capital and DBS Bank co-hosted a closed-door spring exchange at Linear Capital's offices, creating a platform for sharing and discussion. The event introduced portfolio startups working on frontier technology to the latest overseas macro trends, helping them broaden their diverse funding channels.
"DiSight Medical" Cui Di: Solving Pain Points in Fundus and Microsurgery with High-Precision Ophthalmic Surgical Robots | Linear Capital Portfolio Interview Series
In July 2023, Linear Capital portfolio company Hangzhou Disight Medical Biotechnology Co., Ltd. successfully performed a subretinal thrombolysis procedure for treating macular hemorrhage at Zhejiang Provincial People's Hospital using its "Disight MicroEdge" ophthalmic surgical robot — **the first such procedure in Asia**. The company achieved its clinical milestone just two years after founding, and completed [three rounds of financing](https://mp.weixin.qq.com/s/...) in 2023 alone.
Linear Capital-led angel-round portfolio company Xinkong Intelligent announced the completion of a nearly RMB 100 million Series B funding round.
Recently, **Xinkong Intelligent, a Linear Capital seed-round portfolio company and leader in intelligent production-line infrastructure, announced the completion of a nearly RMB 100 million Series B funding round.** This round was led by Xiyu Capital, with follow-on investment from Yima Capital (Hundsun Electronics), and Index Capital served as the exclusive financial advisor.
Linear Capital Leads Angel Round Investment in Yuansuan Technology, Which Completes Hundreds of Millions of Yuan in Series C1 Funding
Recently, Yuansuan Technology, a Linear Capital angel-round lead investment, completed a Series C1 raise of several hundred million RMB. This round was jointly invested by CITIC Securities, Zhejiang Financial Holdings, and others, with existing shareholders including CDH Venture Capital continuing to increase their stakes.
"Yinghua Chenrui" Zhou Zhen: Solving Biomaterial Industry Bottlenecks with Unique Modification Technology and Processing Techniques | Linear Capital Portfolio Interview Series
In late December 2023, bio-based materials high-performance modification and application innovation company **Yinghua Chenrui** announced the completion of a tens of millions of RMB angel funding round.
Multiple Linear Capital portfolio companies selected for Zero2IPO's 2023 Venture50 list
This week, Zero2IPO Holdings and PE Daily announced the results of the 2023 Venture50 rankings. The awards maintained their dual-list structure — the Established Enterprise List and the Emerging Enterprise List, each with a top 50 — alongside five industry-specific lists. The Established Enterprise List covers unlisted companies that have raised beyond Series B or were founded before 2020, while the Emerging Enterprise List covers unlisted companies at Series B or earlier that were founded after 2020. The industry lists include...
Linear Capital portfolio companies Femometer, Rokid, and Whale selected for inaugural Forbes China Globalization 30 & 30
This week, Forbes China released the results of its inaugural "Forbes China · Global Expansion 30 & 30" list. **Linear Capital portfolio companies Femometer, Rokid, and Whale Tech were named "Track Pioneers" in the "2023 Forbes China · Top 30 Global Expansion Brands."** According to information released by Forbes, this year's selection followed an application-based process. Between June and December 2023, the selection committee received hundreds of applications.
Linear Capital｜Linear Path, Nonlinear Growth
We strive to be the best Data Intelligence Technology Fund in China.